Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Brilliant Blue G Double Staining in Macular Surgery
NCT01820520Phase 3Terminated
- Sponsor
- Asociación para Evitar la Ceguera en México
- Start
- Jan 2013
- Primary completion
- Feb 2014
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of brilliant blue G in macular hole, epiretinal membrane (ERM), vitreomacular traction syndrome (VMT), sponsored by Asociación para Evitar la Ceguera en México. Started Jan 2013; status: terminated.
02
Drugs
brilliant blue G
03
Conditions
macular holeepiretinal membrane (ERM)vitreomacular traction syndrome (VMT)
Beyond the preview
Go deeper on NCT01820520.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01820520.